LONDON (Reuters) - Britain has secured 5 million doses of Moderna’s experimental COVID-19 vaccine after interim data indicated it was 94.5% effective, health minister Matt Hancock said on Monday.
“We have today secured an initial agreement for 5 million doses of the Moderna vaccine,” Hancock said at a news conference.
Reporting by William James, writing by Alistair Smout; editing by Michael Holden
Our Standards: The Thomson Reuters Trust Principles.